INTRODUCTION
Sedentary lifestyles and Western diets are changing the face of chronic disease in developed and developing countries. Obesity associated with these lifestyle changes is increasing at an alarming rate. Currently, one in three adults in the US is obese, which is a 75% increase from 1980; 1 the number of obese individuals worldwide has been estimated at 2.1 billion. 2 As a result, the prevalence of obesity-related metabolic dis orders, including insulin resistance, type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, and fatty liver disease, is rising dramatically. In addition to accounting for 6-7% of all-cause mortality in the US, 3 the annual health-care costs for obesityrelated disorders are estimated to be in excess of US$70 billion. 4 Furthermore, if obesity and type 2 diabetes rates continue to increase unabated, especially in children, US life expectancy is predicted to plateau or decrease in the first half of this century. 5 Thus, to blunt the eventual health and financial impact of this epidemic on our society, it is extremely important to understand how obesity leads to insulin resistance and type 2 diabetes. In this Review, we will provide a conceptual framework for understanding the dynamic crosstalk between the immune system and peripheral metabolism, and specifically discuss how obesity leads to the macro phage recruitment and activation that causes insulin resistance.
OBESITY-INDUCED INSULIN RESISTANCE
Studies in humans and mice indicate that type 2 diabetes is a polygenic disease involving peripheral insulin resistance and impaired insulin secretion by pancreatic β cells. 6 Gene knockout studies in mice have shown that the insulin receptor, insulin receptor substrates, glucose transporter 4, peroxisome proliferator-activated receptors (PPARs), oxidative phosphorylation, and retinol binding protein have key roles in the development of insulin resistance and can dramatically modify the phenotypic expression of disease. [7] [8] [9] [10] Environmental factors, such as dietary intake and energy expenditure also have notable effects.
SuMMarY
Chronic inflammation is now recognized as a key step in the pathogenesis of obesity-induced insulin resistance and type 2 diabetes mellitus. This low-grade inflammation is mediated by the inflammatory (classical) activation of recruited and resident macrophages that populate metabolic tissues, including adipose tissue and liver. These findings have led to the concept that infiltration by and activation of macrophages in adipose tissue are causally linked to obesity-induced insulin resistance. Studies have shown, however, that alternatively activated macrophages taking residence in adipose tissue and liver perform beneficial functions in obesity-induced metabolic disease. Alternatively activated macrophages reduce insulin resistance in obese mice by attenuating tissue inflammation and increasing oxidative metabolism in liver and skeletal muscle. The discovery that distinct subsets of macrophages are involved in the promotion or attenuation of insulin resistance suggests that pathways controlling macrophage activation can potentially be targeted to treat these comorbidities of obesity. Thus, this Review focuses on the stimuli and mechanisms that control classical and alternative activation of tissue macrophages, and how these macrophage activation programs modulate insulin action in peripheral tissues. The functional importance of macrophage activation is further discussed in the context of host defense to highlight the crosstalk between innate immunity and metabolism.
These findings suggest that an increase in adiposity somehow physiologically interacts with the genetic parameters that control insulin sensitivity. Indeed, chronic, low-grade inflammation provides a molecular pathway that links obesity to insulin resistance, and its sequela, coronary artery disease. 11, 12 Interestingly, dysregulation of innate immunity, specifically activation of tissue macrophages, is primarily responsible for the observed increase in tissue inflammation in obese mice and humans. 13, 14 
CROSSTALK BETwEEN METABOLISM AND IMMUNITY
The role of inflammation in insulin resistance has become well established during the past decade of intensive research but the complex crosstalk between the immune system and metabolic tissues has been recognized only in the past 5 years. To fully appreciate the molecular dialogue between these essential systems, it is necessary to first review the mechanisms by which the immune system protects the host against attacks. In vertebrates, a layered immune defense confers protection against a myriad of invading pathogens, ranging from viruses to parasites. Cells of the innate immune system, including macrophages, neutrophils, and dendritic cells, provide the first-line of defense against pathogens that breach surface barriers. 15 Recognition of pathogens via germline-encoded patternrecognition receptors initiates signaling that leads to activation of nuclear factor κB (NFκB), a transcription factor required for expression of various proinflam matory and antimicrobial programs. 15, 16 In contrast to the immediate response of innate immune cells, activation of adaptive immune responses occurs 4-7 days later, and is characterized by clonal expansion of T cells and B cells. These T cells and B cells express somatically re arranged receptors, thus conferring antigen-specific and pathogen-specific, longlasting immunity. 17 Although studies have thus far focused on the role of the innate immune system in obesity-induced insulin resistance, it seems likely that molecules elaborated by the adaptive immune system might also regulate nutrient homeostasis and insulin action.
The anatomic juxtaposition of immune and metabolic cell types provides an architectural framework for direct communication between these two fundamental systems. The majority of metabolic organs are densely populated with cells of the innate and adaptive immune system. For instance, liver and white adipose tissues both contain an abundant number of macrophages, whose activation status changes with obesity. [18] [19] [20] [21] In addition, various other immune cell types, including T and B lymphocytes, natural killer T cells, neutrophils, and dendritic cells, are resident in these tissues, and their numbers are known to change during obesity. 22 For instance, while obesity induces a dramatic decrease in the number of natural killer T cells in the liver, 23 the number of activated T cells increases in the white adipose tissue. 24 Adipose tissue and liver also provide the nutrients necessary to sustain activation of innate and adaptive immune responses. 25 Congruent with this idea, nearly all lymph nodes are embedded in depots of white adipose tissue, which provide a dedicated lipid source for fueling immune activa tion. 26 In addition, liver and white adipose tissues are the likely sources for the nutrients, glucose, and fatty acids that sustain the proliferative and secretory programs of activated lymphocytes and myeloid cells, respectively. Indeed, immune activation rapidly and substantially augments this systemic metabolic output. 27 Thus, rapid changes in nutrient flux seem not only to accompany but also to be necessary for immune activation, implying that signals elaborated by immune cells might directly regulate systemic metabolism. Indeed, studies have highlighted a key role for activated macrophages in controlling energy metabolism and insulin action. These topics will be discussed in further detail below.
RECRUITMENT AND ACTIvATION OF ADIPOSE TISSUE MACROPHAGES
Macrophages are a highly heterogeneous cell type found in nearly all tissues of the body. 28 Generally, these cells have been deemed immune sentinels that quiescently monitor the tissue milieu for early signs of infection or damage. In this role, the macrophage is responsible for sensing, integrating, and responding appro priately to a bewildering array of stimuli from its microenvironment. These pleiotropic responses are coordinated through distinct programs of macrophage activation, classified as classical (or M1) or alternative (or M2). 29 www.nature.com/clinicalpractice/endmet cytokines, including inter leukins 4 and 13, promote alternative activation of macrophages, which have known antiparasitic functions and illdefined functions in tissue repair and remodeling (Figures 1 and 2 ). Although a variety of markers are differen tially expressed in these macrophage sub sets (Figure 1 ), 30 the differen tial metabolism of L-arginine provides the most con sistent means of distinguishing these two activation states. 32, 33 While classically acti vated macrophages upregulate inducible nitric oxide synthase to catabolize L-arginine to nitric oxide and citrulline, alternatively activated macro phages preferen tially induce arginase 1, which metabolizes arginine to ornithine and polyamines, precursors necessary for collagen synthesis and cellular proliferation, respectively. 30 As mentioned above, a chronic, low-grade inflam matory state contributes to the comorbid conditions associated with obesity, such as insulin resistance, type 2 diabetes, dyslipidemia, and atherosclerosis. For instance, in obese animals, adipose tissue secretes various pro inflammatory molecules, including tumor necrosis factor (TNF), interleukin 6, and reactive nitrogen species, which directly or indirectly interfere with the insulin signaling pathway. 34 Congruent with these findings, genetic deletion of TNF or inducible nitric oxide synthase greatly attenuates insulin resistance in obese mice. 35, 36 Enlarged adipocytes were originally thought to be the source of proinflammatory molecules, but studies in mice have suggested that bone-marrowderived macrophages are the major culprits. 18 Consistent with this idea, impaired recruitment of macrophages to adipose tissue, as occurs in the C-C motif chemokines receptor 2 or osteopontin knockout mice, reduces inflammation in adipose tissue and improves insulin sensitivity in obese mice. 37 By contrast, adipocyte -specific transgenic expression of monocyte chemoattractant protein 1, the chemo kine ligand for C-C motif chemokines receptor 2, increases recruitment of proinflammatory, classically activated macrophages and potentiates insulin resistance. 38, 39 These findings suggest a paradigm in which infiltration of adipose tissue with macrophages is linked to the development of obesity-induced insulin resistance.
CLASSICALLY ACTIvATED MACROPHAGES PROMOTE INSULIN RESISTANCE
Analysis of macrophages that infiltrate white adipose tissue of obese mice suggests that these cells predominantly express the classically activated phenotype. 13, 14 These observations raise the key question of what stimuli promote the proinflammatory activation of adipose tissue macrophages. Potential insights can be derived from closer inspection of the innate immune response to pathogens. Ligation of Toll-like receptor 4 (TLR4) by bacterially derived lipids, such as lipopolysaccharides, is known to activate inflammatory signaling pathways that induce NFκB to trigger release of various inflammatory molecules, including TNF, interleukins 6 and 12, and inducible nitric oxide synthase (Figure 2 ). 16 The same innate immune module becomes ncpendmet_2008_115f1.eps www.nature.com/clinicalpractice/endmet activated in obesity-induced inflammation and insulin resistance (Figure 2 ). Instead of lipopolysaccharide, in obesity saturated fatty acids, such as myristic, palmitic and stearic fatty acids, activate TLR4 to drive the inflammatory activation of tissue macrophages. [40] [41] [42] Consistent with this notion, acute infusion of lipids into mice potentiates insulin resistance in both adipose tissue and skeletal muscle in a TLR4-dependent manner. 40 Absence of TLR4 confers only partial protection to female mice from inflammation and insulin resistance induced by eating a high-fat diet, suggesting potential involvement of other sex-specific factors, whose identity remains unknown. In addition to TLR4 signaling, chronic overnutrition activates other protein kinases, including IκB kinase β (IKKβ; encoded by Ikbkb in mice) and Jun kinase 1 (JNK1; encoded by Mapk8 in mice), which promote insulin resistance by distinct mechanisms. 34 Activation of the stress kinase JNK1 results in inhibitory serine phosphorylation of insulin receptor substrate 1, leading to decreased tyrosine kinase signaling from the insulin receptor. By contrast, IKKβ activation during obesity releases NFκB from its inhibitor IκB, resulting in increased tissue inflammation. Consistent with their respective roles in stress and inflammatory signaling, global or hepatic deletion of Mapk8 and Ikbkb, respectively, has a profound effect on obesityinduced metabolic disease in mice. While Mapk8 knockout mice are protected from diet-induced obesity and, indirectly, insulin resistance, 43 hepatic deletion of Ikbkb prevents the development of inflammation and insulin resistance in this depot. 44, 45 These data demonstrate that activation of JNK1 and IKKβ in metabolic tissues is, in part, responsible for the onset of insulin resistance in obese animals.
In addition to their role in metabolic tissues, IKKβ and JNK1 seem to be required for classical activation of resident macrophages during obesity. 44 The contribution of myeloid cellspecific IKKβ and hematopoietic cell-specific JNK1 to obesity and insulin resistance have been investigated by two different approaches. For the studies on IKKβ, mice with a cre gene knocked into the lysozyme 2 gene (LysM-cre) were used to delete the floxed IKKβ genes in all myeloid cells, including macrophages and neutro phils. 44 As expected, mice deficient in IKKβ in myeloid cells had lower levels of tissue inflammation and preserved insu lin sensitivity when receiving the high-fat diet. For analysis of JNK1 activity ncpendmet_2008_115f2.eps Figure 2 ).
ALTERNATIvELY ACTIvATED MACROPHAGES PROTECT AGAINST INSULIN RESISTANCE
Although the number of classically activated adipose tissue macrophages increases with obesity, adipose tissue of lean animals also contains a moderate number of macrophages. Adipose tissue macrophages from lean mice express high levels of arginase 1, mannose receptor, dectin-1, Ym1, and macrophage galactose N-acetyl-galactosaminespecific lectins 1 and 2, all of which are encoded by signature genes of alternatively activated macro phages (Figure 1) . 20, 21 Since obesity leads to recruitment of classically activated macrophages, it results in a net shift in the activation state of adipose tissue macrophages from alternative to classical. Furthermore, based on the antiinflammatory activities of alter natively activated macrophages, it has been suggested that these cells might confer protection from the metabolic sequelae of obesity; however, definitive proof for this action is lacking.
To explore the therapeutic potential of alternatively activated macrophages in metabolic disease, we have undertaken a systematic approach in mouse studies to identify the transcriptional switches that control alter native macrophage activation. These studies have revealed that regulators of fatty acid metabo lism play key parts in the acquisition and maintenance of the alternative state. 47 While the T H 2 cytokine interleukin 4 and the signal transducer and activator of transcription 6 (STAT6) provide the initial instructions for alternative macrophage activation, PPARs, the body's sensors of fatty acids, 9 are needed to sustain its expression (Figure 3) . In support of this idea, PPARγ and PPARδ have been shown to bind directly to and activate the macrophage-specific enhancer of arginase 1, a hallmark of alternatively activated macrophages. 21, 48, 49 While PPARγ is required for the metabolic programming of alternatively activated macrophages, 21 PPARδ seems to be important for coordinating the immune programs of these cells, including expression of pattern recognition receptors (encoded by Mrc1 and Clec7a) and co-stimulatory mole cules (Pdcd1lg2), and suppression of the macrophageinflammatory response. 48 Importantly, we discovered that monounsaturated fatty acids, such as oleic acid, synergize with interleukin 4 in a PPARδ-dependent manner to drive the macrophage program of alternative activation.
ncpendmet_2008_115f3.eps Taken together with the previous findings on saturated fatty acids and classical macrophage activation, these data suggest a model in which the local milieu of fatty acids dictates the activation state of tissue macrophages; saturated fatty acids, such as palmitic acid, trigger TLR4/NFκB and JNK1 signaling pathways to promote classical activation of macrophages. Monounsaturated fatty acids, such as oleic acid, however, ligate PPARs to polarize resident macrophages to the anti-inflammatory alternative state (Figure 2 ). By use of mouse models in which alternative activation of tissue macrophages was severely compromised, Odegaard et al. 21, 48 investigated the functions of these cells in obesity-induced metabolic disease. For studies involving PPARγ, macrophage-specific PPARγ knockout mice were generated on the T H 2-permissive Balb/c strain by interbreeding PPARγ floxed and LysM-Cre mice. 21 Expression analysis from lean and obese mice demonstrated that macrophagespecific PPARγ knockout mice had dramatically lower numbers of alternatively activated adipose tissue macrophages. Strikingly, feeding these mice a high-fat diet resulted in moderate obesity and insulin resistance in liver and skele tal muscle, 21, 50 suggesting that alternatively activated adipose tissue macrophages confer protection against the development of metabolic syndrome.
To assess the contribution of PPARδ in alternative macrophage activation and diet-induced metabolic disease, bone marrow from wild type or PPARδ-null mice was transplanted into wild type animals. 48 Analyses of these chimeric animals revealed that hematopoietic deficiency of PPARδ increased both adiposity and peripheral insulin resistance. In marked contrast to what was observed in macrophagespecific PPARγ knockout mice, adoptive transfer of PPARδ-null bone marrow primarily affected alternative activation of Kupffer cells, the resident population of macrophages present in the liver, while sparing the adipose tissue macrophages. 48 Similarly, Kang et al. 51 observed that deletion of PPARδ in myeloid cells decreased alternative activation potential of adipose tissue macrophages, resulting in more severe obesityinduced insulin resistance. In aggregate, these findings suggest that, in a depot-specific manner, PPARδ and PPARγ regulate alternative activation of adipose tissue macrophages and Kupffer cells, respectively, to ameliorate obesity-induced insulin resistance.
A key question that emerges from this work is how alternatively activated macrophages regulate parenchymal cell metabolism. One potential explanation would be that factors released by alternatively activated macrophages act in a paracrine manner to modulate insulin action or cellular metabolism of the parenchymal cells. In support of this theory, co-culture of adipocytes with PPARγ-deficient macrophages led to a dramatic reduction in insulin-stimulated glucose uptake, suggesting that alternatively activated adipose tissue macrophages play an essential part in maintaining adipocyte function. 21, 50 Moreover, deficiency of alternatively activated macrophages in adipose tissue or liver was associated with downregulation of cellular programs for oxidative phosphorylation and β-oxidation in skeletal muscle and liver. Remarkably, this suppressive effect on β-oxidation could be recapitu lated by treating primary hepatocytes with conditioned medium from PPARδ-null macrophages, implying that factors elaborated by alternatively activated macrophages improve the ability of tissues to use incoming fatty acids. 48, 51 While these findings substantially advance our understanding of the dynamic crosstalk that exists between resident alternatively activated macrophages and metabolic tissues, additional investi gations will be neces sary to identify the molecules secreted by macrophages that relay this information to the metabolic tissues in a paracrine or endocrine fashion.
CONCLUSIONS
The collective work on classically and alternatively activated macrophages suggests that macrophage activation plays a dynamic part in modulating insulin sensitivity in animals. Since it is unlikely that good (alternatively activated) and bad (classi cally activated) macro phages were selected for metabolic disease, one must ask why these two macrophage activation states have such a profound effect on insulin action and, indirectly, glucose homeostasis. A potential explanation might be that the decrease in insulin sensitivity that occurs with classi cal macro phage activation is necessary for proper execution of host defense functions. For instance, during acute bacterial infection, such as with Gram-negative rods, activation of the TLR4/NFκB module increases respiratory and inflam matory burst of macrophages, programs necessary for the rapid killing of invading pathogens (Figure 2 program of macro phage activation is bioenergetically demanding and primarily fueled by glyco lysis . 52, 53 Macrophages and neutro phils lack substantial stores of glucose and glycogen and, therefore, they rely heavily on circu lating nutrients to meet their metabolic needs. In support of this viewpoint, TNF increases release of free fatty acids from adipocytes, 54 whereas interleukins 6 and 1α augment fatty acid oxidation and oxidative metabolism in skeletal muscle. 55, 56 Thus, in this context, inflammation-induced insulin resistance is an adaptive response that enables the immune system to have unfettered access to nutrients, including glucose and amino acids, at the expense of peripheral tissues. In the setting of obesity, however, chronic activation of this adaptive response becomes maladaptive, pre disposing mice to obesity-induced insulin resistance and metabolic syndrome (Figure 2) .
A similar paradigm can be invoked for the regulation of peripheral metabolism by alternatively activated macrophages. Rather than conferring protection against bacteria, the T H 2 component of the immune system primarily provides a defense against parasites (Figure 2) . Since this T H 2 immune response is often elicited during the chronic phase of helminth infection, it has been postulated that in this setting the metabolic demands of the immune system are rather different, both in terms of intensity and duration. Accordingly, expression and metabolic profiling of activated macrophages has identified that T H 2 cytokines induce oxidative metabo lism, thereby shifting reliance from glyco lysis to fatty acid oxidation for ATP production. 21, 47 Moreover, since factors elaborated by alter natively activated macrophages increase oxida tive metabolism in peripheral tissues, 21, 48, 51 induction of T H 2 immunity will prevent build up of cytosolic fatty acids and its metabolites, such as acetyl-coenzyme A and diacylglycerol. This shift to oxidative metabolism will have the net effect of reducing lipotoxic effects in liver and skeletal muscle, thereby leading to improvement in insulin action. 57 The bioenergetic demands of an activated immune system drive the changes in insulin sensitivity, which, in this case, result in improvement of glucose homeostasis in obese mice. Thus, this biological interface between innate immunity and metabolism provides new cellular and mole cular targets that can be therapeutically exploited for treatment of comorbidities of obesity, such as insulin resistance, type 2 diabetes mellitus and atherosclerosis. 
